ALLERGAN

Live / Registered — Registered (as of 13 Jul 2021)

What this means for you

Registered since 13 Jul 2021. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
87742107
Registration number
6420206
Mark type
Stylized text
Filed
03 Jan 2018
Published for opposition
17 Apr 2018
Registered
13 Jul 2021
Attorney of record
Cheryl A. Withycombe

Goods and services

  • Class 005 — Pharmaceuticals: House mark used for a line of pharmaceuticals used in connection with anti-aging, the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, facial aesthetic surgery, facial aesthetic reconstruction, breast aesthetics; topical antibiotics, anti-inflammatory, anti-infective, anti-glaucoma and decongestant formulations, and pharmaceutical preparations to treat and prevent glaucoma; ocular wetting solutions, namely, eye drops, artificial tears and gels for the treatment of minor ocular inflammations and allergic conditions; Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain; dermatological formulations, namely, medicated dry skin lotions and creams, acne medications and medicated skin lighteners; Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines for the prevention and treatment of conditions affecting sensory organs; Pharmaceuticals and medicines for the prevention and treatment of conditions affecting the central nervous system; Pharmaceuticals and medicines for the prevention and treatment of conditions affecting urogenital organs; Pharmaceuticals and medicines for the prevention and treatment of conditions affecting circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular disease and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungal preparations; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, central nervous system disorders, neurological disorders, neurodegenerative disorders, and depression, neuroprotective agent; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism; Pharmaceuticals and cosmeceuticals, namely, medicated skin cleansers, toners, moisturizers, rejuvenators, rehydrating creams, and lotions for the face and body; medicated cosmetic skin care preparations
  • Class 010 — Medical apparatus: House mark used for a line of surgical, medical, dental and veterinary apparatus and instruments, namely, diagnostic test kits principally composed of medical diagnostic meters that measure conditions of the cardio-vascular and immune systems; intra-uterine non-chemical contraceptive devices; medical diagnostic instruments for the analysis of body fluids; medical devices for treating glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, and for use in facial aesthetic surgery, facial aesthetic reconstruction, breast aesthetics and ophthalmic related diseases and disorders

Owner

Prior registrations

Prosecution history

  • 13 Jul 2021 — REGISTERED-PRINCIPAL REGISTER
  • 09 Jun 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
  • 08 Jun 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
  • 07 Jun 2021 — STATEMENT OF USE PROCESSING COMPLETE
  • 04 Jun 2021 — USE AMENDMENT FILED
  • 04 Jun 2021 — TEAS STATEMENT OF USE RECEIVED
  • 30 Dec 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 29 Dec 2020 — SOU EXTENSION 5 GRANTED
  • 10 Dec 2020 — SOU EXTENSION 5 FILED
  • 29 Dec 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
  • 10 Dec 2020 — SOU TEAS EXTENSION RECEIVED
  • 16 Jun 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 12 Jun 2020 — SOU EXTENSION 4 GRANTED
  • 12 Jun 2020 — SOU EXTENSION 4 FILED
  • 12 Jun 2020 — SOU TEAS EXTENSION RECEIVED

View this trademark record on Marksy